Skip to main content

Table 3 Levels of serum ceramides

From: Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy

Control Group (n = 15) Sleeve Gastrectomy Group (n = 20)
Ceramide (ng/ml) Preop Po Day 1 Po Day 30 Preop Po Day 1 Po Day 30
C16 CER (d18:1/16:0) 4107,02 ± 461,12 4568,07 ± 265,51 4080,22 ± 503,81 3397,68 ± 217,02 3892,78 ± 401,89 3447,04 ± 183,08
C18 CER (d18:1/18:0) 1312,73 ± 198,25 1498,11 ± 144,02 1103,22 ± 182,85 1188,98 ± 109,14 1361,44 ± 203,41 1213,58 ± 84,05
C20 CER (d18:1/20:0) 1062,13 ± 145,50 1130,25 ± 125,52 983,98 ± 145,01 734,67 ± 79,31 762,52 ± 158,10 650,10 ± 77,73
C22 CER (d18:1/22:0) 6273,70 ± 851,29 6372,18 ± 916,66 7144,98 ± 899,62 5374,87 ± 440,21 3850,60 ± 471,05a,b 3287,03 ± 371,39c,d
C24 CER (d18:1/24:0) 19,706,45 ± 1892,46 22,071,44 ± 3507,56 24,340,62 ± 3289,63 20,507,48 ± 2366,78 14,240,44 ± 1709,18e,f 12,307,39 ± 1400,13g,h
  1. Values are mean ± SEM. Preop, preoperation; Po, postoperation. C16 Ceramide (d18:1/16:0), N-palmitoyl-D-erythro-sphingosine; C18 Ceramide (d18:1/18:0), N-stearoyl-D-erythro-sphingosine; C20 Ceramide (d18:1/20:0), N-arachidoyl-D-erythro-sphingosine; C22 Ceramide (d18:1/22:0), N-behenoyl-D-erythro-sphingosine; C24 Ceramide (d18:1/24:0), N-lignoceroyl-D-erythro-sphingosine
  2. a, p = 0,014 vs. sleeve gastrectomy preop. Statistical analysis was done by paired t-test
  3. b, p = 0,008 vs. control Po Day 1. Statistical analysis was done by t-test
  4. c, p < 0,001 vs. sleeve gastrectomy preop. Statistical analysis was done by paired t-test
  5. d, p < 0,001 vs. control Po Day 30. Statistical analysis was done by t-test
  6. e, p = 0,005 vs. sleeve gastrectomy preop. Statistical analysis was done by paired t-test
  7. f, p = 0,022 vs. control Po Day 1. Statistical analysis was done by t-test
  8. g, p < 0,001 vs. sleeve gastrectomy preop. Statistical analysis was done by paired t-test
  9. h, p < 0,001 vs control Po Day 30. Statistical analysis was done by t-test